Prime Medicine receives FDA clearance for AATD gene therapy

🌐 Investing.com (CY) —
Prime Medicine receives FDA clearance for AATD gene therapy

AI Summary

Prime Medicine has received FDA clearance for its gene therapy targeting Alpha-1 Antitrypsin Deficiency (AATD). This regulatory approval marks an important step forward in addressing genetic diseases through advanced biomedical treatments.

Health Prime Medicine FDA clearance gene therapy AATD genetic diseases biomedical innovation Cyprus

Read original source →